General Information of Drug (ID: DMCDUO1)

Drug Name
5-Hexyl-5-phenyl-imidazolidine-2,4-dione
Synonyms CHEMBL289499
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 260.329
Logarithm of the Partition Coefficient (xlogp) 3.5
Rotatable Bond Count (rotbonds) 6
Hydrogen Bond Donor Count (hbonddonor) 2
Hydrogen Bond Acceptor Count (hbondacc) 2
Chemical Identifiers
Formula
C15H20N2O2
IUPAC Name
5-hexyl-5-phenylimidazolidine-2,4-dione
Canonical SMILES
CCCCCCC1(C(=O)NC(=O)N1)C2=CC=CC=C2
InChI
InChI=1S/C15H20N2O2/c1-2-3-4-8-11-15(12-9-6-5-7-10-12)13(18)16-14(19)17-15/h5-7,9-10H,2-4,8,11H2,1H3,(H2,16,17,18,19)
InChIKey
QUCQUPBUCULYGF-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
44285898
TTD ID
D05XEF

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Sodium channel unspecific (NaC) TTRK8B9 NOUNIPROTAC Inhibitor [1]
Voltage-gated sodium channel alpha Nav1.3 (SCN3A) TTAXZ0K SCN3A_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Comparative molecular field analysis of hydantoin binding to the neuronal voltage-dependent sodium channel. J Med Chem. 1999 May 6;42(9):1537-45.